About Us
Meet The Team
Events
Publications
Careers
Contact Us
Platform
Partnering
Pipeline
News
News
RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.
August 25, 2021
RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement with Zai Lab US, LLC
April 13, 2021
RubrYc Therapeutics To Present at AACR Virtual Conference
June 22, 2020
RubrYc Therapeutics Appoints Ramesh Baliga, Ph.D. as Chief Science Officer
March 17, 2020
RubrYc Therapeutics Announces formation of its Scientific Advisory Board
December 4, 2019
RubrYc Therapeutics appoints Jean Viret, Ph.D. to its Board of Directors
November 6, 2018
RubrYc Therapeutics Winner of the 2018 Xcelerate Startup Pitch Competition
September 6, 2018
RubrYc Therapeutics Presents at the New York Venture Summit
July 10, 2018
RubrYc Therapeutics Completes $10M Million Series A Financing
April 10, 2018
